Hepatic Arterial Infusion Chemotherapy with Use of an Implanted Port System in Patients with Advanced Hepatocellular Carcinoma: Prognostic Factors
Autor: | Ayumi Hamada, Atsuhiro Nakatsuka, Koichiro Yamakado, Kan Takeda, Haruyuki Takaki, Masao Akeboshi |
---|---|
Rok vydání: | 2004 |
Předmět: |
Adult
Male medicine.medical_specialty Carcinoma Hepatocellular medicine.medical_treatment Gastroenterology Catheters Indwelling Hepatic Artery Internal medicine Antineoplastic Combined Chemotherapy Protocols Ascites medicine Humans Infusions Intra-Arterial Radiology Nuclear Medicine and imaging Prospective cohort study Transcatheter arterial chemoembolization Aged Epirubicin Retrospective Studies Univariate analysis business.industry Liver Neoplasms Therapeutic effect Cancer Middle Aged Prognosis medicine.disease Survival Analysis Surgery Treatment Outcome Doxorubicin Hepatocellular carcinoma Multivariate Analysis Female Fluorouracil Cisplatin Percutaneous ethanol injection medicine.symptom Cardiology and Cardiovascular Medicine business Follow-Up Studies |
Zdroj: | Journal of Vascular and Interventional Radiology. 15:835-841 |
ISSN: | 1051-0443 |
DOI: | 10.1097/01.rvi.0000128815.35555.0e |
Popis: | PURPOSE This study was retrospectively undertaken to identify prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated by hepatic arterial infusion chemotherapy with a percutaneously implantable port system inserted. MATERIALS AND METHODS Eighty-eight patients underwent arterial infusion chemotherapy for portal venous invasion ( n = 39), severe liver dysfunction ( n = 6), or tumor regrowth after chemoembolization, percutaneous ethanol injection therapy, and surgery ( n = 77). Twenty-five variables representing patients' characteristics, previous treatments, tumor characteristics, liver profiles, various staging systems, and therapeutic effect were analyzed with univariate and multivariate analyses. RESULTS The 1-and 3-year survival rates were 55% and 24%, respectively, with a mean survival period of 19.5 months ± 1.9 in all patients. Cancer of the Liver Italian Program (CLIP) score, Okuda stage, therapeutic effect, tumor extension, alkaline phosphatase and aspartate aminotransferase levels, ascites, and portal venous invasion were identified as significant prognostic factors by univariate analysis. Multivariate analysis identified CLIP score, Okuda stage, and therapeutic effect as significant independent prognostic factors. CONCLUSION Although our results should be confirmed in future prospective studies, the prognostic factors identified in the present study should prove helpful in classifying patients with advanced HCC who are treated by arterial infusion chemotherapy and should serve as useful guidelines on arterial infusion chemotherapy in clinical practice. |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.